143 related articles for article (PubMed ID: 8108982)
1. Use of granulocyte-macrophage colony-stimulating factor in leukopenic renal transplant recipients.
Page B; Morin MP; Mamzer MF; Thervet E; Legendre C
Transplant Proc; 1994 Feb; 26(1):283. PubMed ID: 8108982
[No Abstract] [Full Text] [Related]
2. Granulocyte macrophage colony-stimulating factor for the therapy of cytomegalovirus and ganciclovir-induced leukopenia in a renal transplant recipient.
Kutsogiannis DJ; Crowther MA; Lazarovits AI
Transplantation; 1992 Apr; 53(4):930-2. PubMed ID: 1314441
[No Abstract] [Full Text] [Related]
3. Use of granulocyte-macrophage colony-stimulating factor for reversal of neutropenia following combined kidney-pancreas transplantation.
Squiers EC; Elkhammas EA; Henry ML
Transplant Proc; 1995 Dec; 27(6):3092-3. PubMed ID: 8539860
[No Abstract] [Full Text] [Related]
4. The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient.
Derici U; Ayerdem F; Arinsoy T; Reis KA; Dalgic A; Sindel S
Haematologia (Budap); 2002; 32(4):557-60. PubMed ID: 12803133
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte colony-stimulating factor. A new application for cytomegalovirus-induced neutropenia in cardiac allograft recipients.
Patel HD; Anderson JR; Duncombe AS; Carrington D; Murday A
Transplantation; 1994 Oct; 58(7):863-7. PubMed ID: 7940727
[No Abstract] [Full Text] [Related]
6. Granulocyte colony-stimulating factors.
Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
[No Abstract] [Full Text] [Related]
7. [Rational therapy with G-CSF and GM-CSF].
Link H; Herrmann F; Welte K; Aulitzky WE; Ganser A; Kern WV; Meyer P; Schrappe M; Schmoll HJ; Werdan K
Med Klin (Munich); 1994 Aug; 89(8):429-41. PubMed ID: 7526144
[No Abstract] [Full Text] [Related]
8. [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias].
Garavelli PL; Berti P
Recenti Prog Med; 1993; 84(7-8):526-30. PubMed ID: 8356307
[TBL] [Abstract][Full Text] [Related]
9. Treatment of leukopenia with granulocyte-macrophage colony-stimulating factor after heart transplantation.
Wasler A; Iberer F; Auer T; Petutschnigg B; Müller H; Pfeifer J; Deutsch T; Tscheliessnigg KH
Transplant Proc; 1995 Oct; 27(5):2633-4. PubMed ID: 7482859
[No Abstract] [Full Text] [Related]
10. [Colony stimulating factors in blood formation].
Goebel M
Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():51-6. PubMed ID: 7531048
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-macrophage colony-stimulating factor in neutropenia.
Hogan KR; Peters MD
DICP; 1991 Jan; 25(1):32-5. PubMed ID: 2008785
[No Abstract] [Full Text] [Related]
12. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
Page AV; Liles WC
Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
[TBL] [Abstract][Full Text] [Related]
13. [Primary cytomegalovirus infection causing a kidney transplant patient to develop cryoagglutinins and cryoglobulins].
Fernández EJ; Auyanet I; Guerra R; Pérez MA; Bosch E; Ramírez A; Suria S; Checa MD
Nefrologia; 2010; 30(2):267-8. PubMed ID: 20393633
[No Abstract] [Full Text] [Related]
14. Recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in leukopenic patients with advanced HIV disease.
Manfredi R; Mastroianni A; Coronado O; Chiodo F
J Chemother; 1996 Jun; 8(3):214-20. PubMed ID: 8808719
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of molgramostim in marrow transplant recipients.
Ippoliti C; Przepiorka D; Smith T; Maiese S; Giralt S; Andersson BS; Deisseroth AB; Champlin RE
Clin Pharm; 1993 Jul; 12(7):520-5. PubMed ID: 8354039
[No Abstract] [Full Text] [Related]
16. [New specialty drugs admitted in Austria and new knowledge regarding drugs already in longer use. Leucomax-Aesca dry injection ampule with solution. Leucomax-Sandoz dry injection ampule with solution].
Haas R
Wien Klin Wochenschr; 1993; 105(10):299-305. PubMed ID: 8390767
[No Abstract] [Full Text] [Related]
17. Use of granulocyte-macrophage colony-stimulating factor in hematopoietic disorders: biology and nature of response.
Vadhan-Raj S; Broxmeyer HE; Hittelman WN
Semin Hematol; 1992 Oct; 29(4 Suppl 3):4-13. PubMed ID: 1492234
[No Abstract] [Full Text] [Related]
18. Granulocyte-macrophage colony-stimulating factor given before dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP).
Holdsworth MT; Roon R; Ferguson J; Martinez L; Stidley CA; Neidhart JA
Biotechnol Ther; 1993; 4(3-4):183-95. PubMed ID: 8292969
[TBL] [Abstract][Full Text] [Related]
19. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on HIV-related leukopenia: a randomized, controlled clinical study.
Barbaro G; Di Lorenzo G; Grisorio B; Soldini M; Barbarini G
AIDS; 1997 Oct; 11(12):1453-61. PubMed ID: 9342067
[TBL] [Abstract][Full Text] [Related]
20. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
Root RK; Dale DC
J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
